Immediate Impact

1 by Nobel laureates 7 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
3 intermediate papers

Works of Michael Petrus being referenced

Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin’s lymphoma
2016
Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2–dependent adult T-cell leukemia
2015
and 1 more

Author Peers

Author Last Decade Papers Cites
Michael Petrus 434 301 144 187 24 732
Masanori Taniguchi 243 236 206 246 24 684
Matthew A. Care 241 142 181 409 34 795
Anthony Warford 184 166 131 269 25 652
T Otsuka 299 175 49 183 23 767
Yong‐Jun Liu 453 120 83 190 14 715
Vadim Deyev 452 234 166 146 17 745
Yukiyo Matsushita 287 81 292 179 22 765
Leah J. Hogdal 200 233 71 408 20 811
Angelo Messina 235 395 93 254 25 759
Piotr Grabarczyk 220 187 97 329 36 647

All Works

Loading papers...

Rankless by CCL
2026